Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Endocr Metab Immune Disord Drug Targets. 2021;21(10):1895-1904. doi: 10.2174/1871530320999201209222921.
Endocr Metab Immune Disord Drug Targets. 2021.
PMID: 33302842
Efficacy of probiotic supplementation in patients with diabetic nephropathy: A systematic review and meta-analysis.
AbdelQadir YH, Hamdallah A, Sibaey EA, Hussein AS, Abdelaziz M, AbdelAzim A, Ragab KM, Helmy SK, Nourelden AZ.
AbdelQadir YH, et al. Among authors: helmy sk.
Clin Nutr ESPEN. 2020 Dec;40:57-67. doi: 10.1016/j.clnesp.2020.06.019. Epub 2020 Sep 19.
Clin Nutr ESPEN. 2020.
PMID: 33183573
Item in Clipboard
Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes.
Zaazouee MS, Hamdallah A, Helmy SK, Hasabo EA, Sayed AK, Gbreel MI, Elmegeed AA, Aladwan H, Elshanbary AA, Abdel-Aziz W, Elshahawy IM, Rabie S, Elkady S, Ali AS, Ragab KM, Nourelden AZ.
Zaazouee MS, et al. Among authors: helmy sk.
Diabetes Metab Syndr. 2022 Jun;16(6):102511. doi: 10.1016/j.dsx.2022.102511. Epub 2022 May 20.
Diabetes Metab Syndr. 2022.
PMID: 35623229
Item in Clipboard
Cite
Cite